Closed due to insufficient recruitment.

The aim of the study is to determine if Iressa is effective in the treatment of Brain metastases from NCSLC

Inclusion Criteria:

• Radiologically confirmed brain metastases from Non Small Cell Lung Cancer
• No symptoms due to brain metastases
• No previous radiotherapy treatment for the Brain metastases

Exclusion Criteria:

• No prior chemotherapy
• No other co-existing malignancies or malignancies diagnosed within the last 5 years with the exception of basal cell carcinoma or cervical cancer in situ
• Any evidence of severe or uncontrolled systemic disease (e.g., unstable or uncompensated respiratory, cardiac, hepatic, or renal disease)